Uncomplicated Urinary Tract Infection
FDA approves first new antibiotic for uncomplicated UTIs in nearly 30 years
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, GSK announced.
Lower cutoff optimizes UTI diagnosis in children undergoing bladder catheterization
Data from a new study suggested a new standard cutoff for determining urinary tract infections in febrile children undergoing bladder catheterization, according to results published in Pediatrics.
Twice-daily cephalexin safe, effective for women with uncomplicated UTI
Cephalexin given twice daily is as effective as a regimen of four daily doses for treating women with uncomplicated UTIs, researchers reported.
Uncomplicated UTIs decrease quality of life, productivity, health
Women with uncomplicated urinary tract infections reported negative effects on their sleep, exercise, sexual function, productivity and health-related quality of life, according to findings published in PLOS ONE.
High percentage of uncomplicated UTI not susceptible to initial treatment
New antimicrobial dispensing within 28 days of initial treatment was associated with uncomplicated UTIs where the uropathogen was not susceptible to initial treatment, according to a recent study.
Fluoroquinolone use decreases following FDA black box warning
The FDA black box warning on fluoroquinolones that was issued in 2016 resulted in a significant, further decline in use at 29 southeastern U.S. hospitals, according to a recent study published in Infection Control and Hospital Epidemiology.